Logo

Medtronic to Acquire Avenu Medical

Share this

Medtronic to Acquire Avenu Medical

Shots:

  • Medtronic acquires Avenu Medical for its Percutaneous Fistula Creation Technology that will foster Medtronic’s peripheral vascular access portfolio and improves outcomes for patients with ESRD undergoing dialysis. The acquisition is expected to close in Oct’2020
  • The acquisition allows Medtronic to bring less invasive- endovascular solutions to patients requiring durable vascular access. This marks the sixth acquisitions that Medtronic has made in 2020
  • Avenu Medical's Ellipsys Vascular Access system is a single-catheter- ultrasound-guided device that inserts a catheter percutaneously into the arm to create a durable AV fistula and has received CE Mark in the EU & is the US FDA approved

­ Ref: Medtronic | Image: Avenu Medical

Click here to­ read the full press release 

Senior Editor

This content piece was prepared by our former Senior Editor. She had expertise in life science research and was an avid reader. For any query reach out to us at connect@pharmashots.com

Share this article on WhatsApp, LinkedIn and Twitter

Join the PharmaShots family of 12000+ subscribers

I accept the Terms and Conditions